Results (
Thai) 1:
[Copy]Copied!
คัดออก 11• Receipt of previous antiretrovirals > 1 week duration, other than ZDV during a current or prior pregnancy (receipt of SD NVP in a prior pregnancy is not an exclusion).• Plan to formula feed.NOTE: Actual feeding practices will be monitored at each visit, and formula feeding while on-study will not affect continued study participation.• Known pre-existing fetal anomalies resulting in a high probability that the fetus will not survive to 6 months.• Known pre-existing allergy/sensitivity to study drugs that might be received.• Known medical condition or concomitant medications incompatible with study drugs the participant might receive.• Previous participation in Mashi Study or vaccine intervention study.• This study is not be suitable for prisoner participation, per 45 US CFR 46.306(a)(2)(D).Note: If a mother goes into labour after she has consented to enroll in the study but before she has been randomised, she will no longer be eligible to participate in the study during that pregnancy. She will be referred to the Botswana PMTCT programme or The Botswana National ART programme as appropriate.
Being translated, please wait..